A5075407335- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Organ Transplantation Techniques and Outcomes
- Hepatitis B Virus Studies
- Liver Diseases and Immunity
- Hepatocellular Carcinoma Treatment and Prognosis
- COVID-19 Clinical Research Studies
- Alcohol Consumption and Health Effects
- Long-Term Effects of COVID-19
- Gallbladder and Bile Duct Disorders
- Pneumocystis jirovecii pneumonia detection and treatment
- COVID-19 and healthcare impacts
- COVID-19 Impact on Reproduction
- Parasitic Infections and Diagnostics
- Drug-Induced Hepatotoxicity and Protection
- Pediatric Hepatobiliary Diseases and Treatments
- Cytomegalovirus and herpesvirus research
- Amoebic Infections and Treatments
- Endoplasmic Reticulum Stress and Disease
- Bioactive Natural Diterpenoids Research
- Eosinophilic Disorders and Syndromes
- Research on Leishmaniasis Studies
- Organ Donation and Transplantation
- Rabies epidemiology and control
- Renal Transplantation Outcomes and Treatments
Medanta The Medicity
2019-2024
Medanta The Medicity
2019-2023
Post Graduate Institute of Medical Education and Research
2016
BackgroundCoronavirus disease 2019 (COVID-19) pandemic has led to deferral of elective transplants and proactive pretransplant testing the donor/recipient. The impact these on living-donor liver transplantation (LDLT) activity outcome is not known. We performed LDLT only for sick patients or with advanced hepatocellular carcinoma in this period, special COVID protocols.MethodsPatients undergoing counseling, evaluation, transplant period March June 2020 (group A) under COVID-19 restrictions...
Potential conflict of interest: Nothing to report. To the Editor: The coronavirus disease 2019 (COVID‐19) outbreak started in China December and then rapidly spread all over world, infecting more than 20 million people causing 700,000 deaths. Overall mortality COVID‐19 is 3%‐4%,(1) which generally happens patients with older age comorbidities. No evidence‐based treatment has been approved so far,(2) outcomes liver transplantation (LT) recipients are not well known at present. In a...
ABO incompatibility, donor liver steatosis, and low graft-to-recipient body weight ratio (GRWR) are the most common reasons for rejection of living donors. Apart from ABO-incompatible dual-lobe living-donor transplantation (LDLT), problems blood group incompatibility GRWR can be overcome with paired exchange (PE)-LDLT. PE-LDLT between 2 recipient-donor pairs has been performed at many high-volume centers including ours (experience 44 to date) over a decade,1,2 as strategy expand pool, by...
Abstract The word endo-hepatology evokes many perceptions. Some believe it to be the emerging new interventional branch and some an extension of endoscopy. Nonetheless, has continued evolve into exciting area active work. With advent endoscopic ultrasound (EUS) based procedures, vistas have opened up. EUS-guided liver biopsies, portal hypertension management, multiple procedures are being described. EUS also plays a large role in management patients peritransplant period. this review, we...